Lu Da-Yong, Wu Fu-Geng, Zhen Zu-Ming, Lu Ting-Ren, Wu Hong-Ying, Che Jin-Yu, Xu Bin
Shanghai University, Shanghai 200444, PR China.
Sci Pharm. 2010 Jan-Mar;78(1):13-20. doi: 10.3797/scipharm.0910-16. Epub 2009 Dec 29.
Spontaneous neoplasm metastasis, a fatalist pathological feature of cancer, is a long-evolving, multi-steps process that can now only be treated or controlled by drugs or immuno-modulators. As we have previously hypothesized, each drug or immuno-modulator might act differently within various stages of a metastasis. Therefore any researches helping to determine these differences will be beneficial for updating therapeutics for metastasis. In this work, we have testified this hypothesis by using a series of well-known anti-metastatic agents â Bisdioxopiperazine compounds.
肿瘤自发转移是癌症的一个致命病理特征,是一个长期演变的多步骤过程,目前只能通过药物或免疫调节剂进行治疗或控制。正如我们之前所假设的,每种药物或免疫调节剂在转移的各个阶段可能有不同的作用。因此,任何有助于确定这些差异的研究都将有利于更新转移治疗方法。在这项工作中,我们通过使用一系列著名的抗转移剂——双二氧哌嗪化合物验证了这一假设。